<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//campaign.triplehair.ca/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://campaign.triplehair.ca/publications/</loc>
		<lastmod>2026-06-08T00:45:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/finaliste-au-bio-digital-start-up-stadium-et-financement/</loc>
		<lastmod>2020-06-23T03:07:27+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/BIO.jpg</image:loc>
			<image:title><![CDATA[BIO]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-retains-endoceutics-8/</loc>
		<lastmod>2020-06-23T03:07:39+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/hans-reniers-lQGJCMY5qcM-unsplash-scaled.jpg</image:loc>
			<image:title><![CDATA[hans-reniers-lQGJCMY5qcM-unsplash]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/corporate-update/</loc>
		<lastmod>2020-06-23T03:07:49+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/coronavirus.jpg</image:loc>
			<image:title><![CDATA[coronavirus]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/vp-business-development-appointment/</loc>
		<lastmod>2020-06-23T03:08:02+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/Screen-Shot-2020-06-15-at-12.01.18-PM.png</image:loc>
			<image:title><![CDATA[Screen Shot 2020-06-15 at 12.01.18 PM]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/nouvellenomination/</loc>
		<lastmod>2020-06-23T03:08:13+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/Screen-Shot-2020-06-15-at-11.55.42-AM.png</image:loc>
			<image:title><![CDATA[Screen Shot 2020-06-15 at 11.55.42 AM]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/nominationalahautedirection/</loc>
		<lastmod>2020-06-23T03:08:27+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/01/erika.jpg</image:loc>
			<image:title><![CDATA[erika]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/excellent-article-sur-triplehairdansletimestranscript/</loc>
		<lastmod>2020-06-23T03:08:40+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/article_1.jpg</image:loc>
			<image:title><![CDATA[article_1]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-retains-endoceutics-8/</loc>
		<lastmod>2020-06-23T03:09:04+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/hans-reniers-lQGJCMY5qcM-unsplash-scaled.jpg</image:loc>
			<image:title><![CDATA[hans-reniers-lQGJCMY5qcM-unsplash]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/corporate-update/</loc>
		<lastmod>2020-06-23T03:09:16+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/coronavirus.jpg</image:loc>
			<image:title><![CDATA[coronavirus]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/vp-business-development-appointment/</loc>
		<lastmod>2020-06-23T03:09:28+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/Screen-Shot-2020-06-15-at-12.01.18-PM.png</image:loc>
			<image:title><![CDATA[Screen Shot 2020-06-15 at 12.01.18 PM]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/newappointment/</loc>
		<lastmod>2020-06-23T03:09:40+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/Screen-Shot-2020-06-15-at-11.55.42-AM.png</image:loc>
			<image:title><![CDATA[Screen Shot 2020-06-15 at 11.55.42 AM]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/executiveappointment/</loc>
		<lastmod>2020-06-23T03:09:52+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/01/erika.jpg</image:loc>
			<image:title><![CDATA[erika]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/times-transcript/</loc>
		<lastmod>2020-06-23T03:10:03+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/article_1.jpg</image:loc>
			<image:title><![CDATA[article_1]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/bio-digital-start-up-stadium-finalist-and-financing/</loc>
		<lastmod>2020-06-23T04:00:32+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2020/06/BIO.jpg</image:loc>
			<image:title><![CDATA[BIO]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/q4-2021-investors-news/</loc>
		<lastmod>2021-10-15T01:14:44+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2021/10/publication-header-q4-2021.jpg</image:loc>
			<image:title><![CDATA[publication-header-q4-2021]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/nouvelles-pour-investisseurs-t4-2021/</loc>
		<lastmod>2021-10-15T01:15:48+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2021/10/publication-header-q4-2021.jpg</image:loc>
			<image:title><![CDATA[publication-header-q4-2021]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-adds-further-expertise-to-board/</loc>
		<lastmod>2021-12-07T14:14:58+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2021/11/header-publication-pressrelease.jpg</image:loc>
			<image:title><![CDATA[header-publication-pressrelease]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-renforce-son-conseil-dadministration/</loc>
		<lastmod>2021-12-07T14:15:56+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2021/11/header-publication-pressrelease.jpg</image:loc>
			<image:title><![CDATA[header-publication-pressrelease]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-announces-the-launch-of-rizn/</loc>
		<lastmod>2021-12-07T15:20:11+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2021/12/Groupe-2390-e1638890215194.jpg</image:loc>
			<image:title><![CDATA[Groupe 2390]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-announces-the-launch-of-plenty-natural/</loc>
		<lastmod>2022-04-14T21:39:04+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2022/04/plenty-natural-products.jpg</image:loc>
			<image:title><![CDATA[plenty-natural-products]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-annonce-le-lancement-de-rizn/</loc>
		<lastmod>2022-04-14T21:40:34+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2021/12/Groupe-2390-e1638890215194.jpg</image:loc>
			<image:title><![CDATA[Groupe 2390]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-annonce-le-lancement-de-plenty-natural/</loc>
		<lastmod>2022-04-14T21:40:49+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2022/04/plenty-natural-products.jpg</image:loc>
			<image:title><![CDATA[plenty-natural-products]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-announces-strategic-arrangement-with-leading-us-compounding-company-pharmacy-solutions/</loc>
		<lastmod>2022-06-28T14:10:05+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2022/06/pharmacysolutions_logo.png</image:loc>
			<image:title><![CDATA[pharmacysolutions_logo]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-annonce-un-accord-strategique-avec-pharmacy-solutions-un-chef-de-file-americain-dans-la-preparation-de-medicaments/</loc>
		<lastmod>2022-06-28T17:09:57+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2022/06/pharmacysolutions_logo.png</image:loc>
			<image:title><![CDATA[pharmacysolutions_logo]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/new-possibilities-in-hair-loss-prescription-therapies/</loc>
		<lastmod>2022-08-11T20:42:49+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2022/08/Untitled-design-6.png</image:loc>
			<image:title><![CDATA[Untitled design (6)]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/des-progres-dans-les-traitements-sur-ordonnance-pour-lalopecie/</loc>
		<lastmod>2022-08-11T20:43:19+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2022/08/Untitled-design-6.png</image:loc>
			<image:title><![CDATA[Untitled design (6)]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-annonce-des-resultats-positifs-des-etudes-dinnocuite-sur-son-medicament-sur-ordonnance-therapie-07/</loc>
		<lastmod>2023-06-14T13:41:43+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/3.png</image:loc>
			<image:title><![CDATA[3]]></image:title>
			<image:caption><![CDATA[Laboratoire]]></image:caption>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-reports-positive-results-from-safety-studies-on-its-therapy-07-prescription-drug/</loc>
		<lastmod>2023-06-14T13:43:00+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/3.png</image:loc>
			<image:title><![CDATA[3]]></image:title>
			<image:caption><![CDATA[Laboratoire]]></image:caption>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-consolidates-its-position-as-industry-leader-and-innovator-for-its-therapy-07-prescription-drug-in-the-u-s/</loc>
		<lastmod>2023-06-19T13:30:58+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/Cr%C3%A9ation-sans-titre-1.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-consolide-sa-position-dinnovateur-et-de-leader-dindustrie-pour-son-medicament-sur-ordonnance-therapie-07-aux-etats-unis/</loc>
		<lastmod>2023-06-19T13:32:04+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/Cr%C3%A9ation-sans-titre-1.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/can-anxiety-or-even-mental-health-affect-hair-loss/</loc>
		<lastmod>2023-06-22T14:19:07+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/Cr%C3%A9ation-sans-titre-5.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
			<image:caption><![CDATA[picture]]></image:caption>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/lanxiete-ou-la-sante-mentale-peuvent-elles-affecter-la-perte-de-cheveux/</loc>
		<lastmod>2023-06-22T14:20:26+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/Cr%C3%A9ation-sans-titre-5.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
			<image:caption><![CDATA[picture]]></image:caption>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-receives-health-canada-approval-to-start-phase-iii-clinical-trials-on-its-therapy-07-prescription-drug-in-canada/</loc>
		<lastmod>2023-06-28T13:28:53+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/Cr%C3%A9ation-sans-titre-6.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-recoit-lapprobation-de-sante-canada-pour-commencer-les-essais-cliniques-de-phase-iii-sur-son-medicament-sur-ordonnance-therapie-07-au-canada/</loc>
		<lastmod>2023-06-28T13:29:48+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/06/Cr%C3%A9ation-sans-titre-6.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/opportunitiesnb-article-on-an-interview-with-our-ceo-jean-phillipe-gravel/</loc>
		<lastmod>2023-07-27T18:02:34+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/07/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/article-opportunitesnb-portant-sur-une-interview-avec-notre-ceo-jean-phillipe-gravel/</loc>
		<lastmod>2023-07-27T18:03:38+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/07/Cr%C3%A9ation-sans-titre-5.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-signe-une-entente-de-licence-avec-mothers-pharmaceutical-pour-le-marche-sud-coreen/</loc>
		<lastmod>2023-10-17T12:29:14+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/10/2.png</image:loc>
			<image:title><![CDATA[2]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-wins-jurys-choice-award-at-octane-aesthetic-tech-forum-conference/</loc>
		<lastmod>2024-02-12T15:11:55+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/02/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[CEO win a trophy at Octane OC]]></image:title>
			<image:caption><![CDATA[CEO win a trophy at Octane OC]]></image:caption>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-remporte-le-jurys-choice-award-a-la-conference-octane-aesthetic-tech-forum/</loc>
		<lastmod>2024-02-12T15:25:53+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/02/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
			<image:caption><![CDATA[CEO win a trophy]]></image:caption>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-signs-licensing-agreement-for-south-korean-market-with-mothers-pharmaceutical/</loc>
		<lastmod>2024-02-15T14:40:31+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2023/10/2-1.png</image:loc>
			<image:title><![CDATA[2]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-closes-4-million-financing/</loc>
		<lastmod>2024-06-03T17:52:40+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/06/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-procede-a-la-cloture-dun-financement-de-4-m/</loc>
		<lastmod>2024-06-03T17:54:01+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/06/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-lune-des-jeunes-pousses-en-vedette-dans-le-journal-de-montreal/</loc>
		<lastmod>2024-06-11T15:59:01+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/06/6.png</image:loc>
			<image:title><![CDATA[6]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hairs-feature-in-le-journal-de-montreal/</loc>
		<lastmod>2024-06-11T15:59:33+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/06/6.png</image:loc>
			<image:title><![CDATA[6]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-recoit-lapprobation-de-lema-pour-commencer-les-essais-cliniques-de-phase-iii-sur-son-medicament-sur-ordonnance-therapie-07-en-europe/</loc>
		<lastmod>2024-06-19T13:39:31+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/06/Cr%C3%A9ation-sans-titre-3.png</image:loc>
			<image:title><![CDATA[Création sans titre-3]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-receives-ema-approval-to-start-phase-iii-clinical-trials-on-its-therapy-07-prescription-drug-in-europe/</loc>
		<lastmod>2024-06-19T13:40:34+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/06/Cr%C3%A9ation-sans-titre-3.png</image:loc>
			<image:title><![CDATA[Création sans titre-3]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-conclut-une-entente-de-licence-avec-akums-pour-therapie-07-en-inde/</loc>
		<lastmod>2024-10-23T14:26:25+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/10/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-enters-into-licensing-agreement-with-akums-for-therapy-07-in-india/</loc>
		<lastmod>2024-10-23T14:27:35+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2024/10/Cr%C3%A9ation-sans-titre.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/etude-clinique-de-th07-publiee-dans-une-revue-scientifique/</loc>
		<lastmod>2025-04-08T00:49:30+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2025/04/Ajouter-un-sous-titre.png</image:loc>
			<image:title><![CDATA[Ajouter un sous-titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/th07-clinical-study-featured-in-peer-reviewed-journal/</loc>
		<lastmod>2025-04-08T00:50:52+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2025/04/Ajouter-un-sous-titre.png</image:loc>
			<image:title><![CDATA[Ajouter un sous-titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-renforce-son-equipe-de-direction-avec-la-nomination-de-paul-sowyrda-a-son-conseil-dadministration/</loc>
		<lastmod>2025-05-28T07:00:23+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2025/05/Paul-Sowyrda_picture-5.png</image:loc>
			<image:title><![CDATA[Paul Sowyrda_picture-5]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-strengthens-leadership-team-with-appointment-of-paul-sowyrda-to-its-board-of-directors/</loc>
		<lastmod>2025-05-28T11:33:18+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2025/05/Paul-Sowyrda_picture-5.png</image:loc>
			<image:title><![CDATA[Paul Sowyrda_picture-5]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-group-signs-licensing-agreement-for-the-brazilian-market-with-ache/</loc>
		<lastmod>2025-06-23T08:00:57+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2025/06/Jean-Philippe-Gravel-CEO-5.png</image:loc>
			<image:title><![CDATA[Jean-Philippe Gravel CEO-5]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hairs-feature-in-the-ny-post/</loc>
		<lastmod>2026-03-25T00:09:06+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2026/03/Cr%C3%A9ation-sans-titre-1.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-group-signe-une-entente-de-licence-pour-le-marche-bresilien-avec-ache/</loc>
		<lastmod>2026-04-02T07:00:16+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2026/03/Cr%C3%A9ation-sans-titre-2.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-doses-first-patient-in-phase-iii-clinical-trial-in-canada-for-male-androgenic-alopecia/</loc>
		<lastmod>2026-04-02T07:00:55+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2026/03/Cr%C3%A9ation-sans-titre-2.png</image:loc>
			<image:title><![CDATA[Création sans titre]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/triple-hair-expands-global-phase-iii-program-for-th07-with-launch-of-500-patient-trial-in-india/</loc>
		<lastmod>2026-05-14T07:30:12+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2026/05/Ajouter-un-sous-titre-2.png</image:loc>
			<image:title><![CDATA[Ajouter un sous-titre-2]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/triple-hair-elargit-son-programme-mondial-de-phase-iii-pour-th07-avec-le-lancement-dun-essai-clinique-de-500-patients-en-inde/</loc>
		<lastmod>2026-06-08T00:45:28+00:00</lastmod>
		<image:image>
			<image:loc>https://campaign.triplehair.ca/wp-content/uploads/2026/05/Ajouter-un-sous-titre-2.png</image:loc>
			<image:title><![CDATA[Ajouter un sous-titre-2]]></image:title>
		</image:image>
	</url>
	<url>
		<loc>https://campaign.triplehair.ca/fr/publications/</loc>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->